Literature DB >> 20030886

The HTA core model: a novel method for producing and reporting health technology assessments.

Kristian Lampe1, Marjukka Mäkelä, Marcial Velasco Garrido, Heidi Anttila, Ilona Autti-Rämö, Nicholas J Hicks, Björn Hofmann, Juha Koivisto, Regina Kunz, Pia Kärki, Antti Malmivaara, Kersti Meiesaar, Päivi Reiman-Möttönen, Inger Norderhaug, Iris Pasternack, Alberto Ruano-Ravina, Pirjo Räsänen, Ulla Saalasti-Koskinen, Samuli I Saarni, Laura Walin, Finn Børlum Kristensen.   

Abstract

OBJECTIVES: The aim of this study was to develop and test a generic framework to enable international collaboration for producing and sharing results of health technology assessments (HTAs).
METHODS: Ten international teams constructed the HTA Core Model, dividing information contained in a comprehensive HTA into standardized pieces, the assessment elements. Each element contains a generic issue that is translated into practical research questions while performing an assessment. Elements were described in detail in element cards. Two pilot assessments, designated as Core HTAs were also produced. The Model and Core HTAs were both validated. Guidance on the use of the HTA Core Model was compiled into a Handbook.
RESULTS: The HTA Core Model considers health technologies through nine domains. Two applications of the Model were developed, one for medical and surgical interventions and another for diagnostic technologies. Two Core HTAs were produced in parallel with developing the model, providing the first real-life testing of the Model and input for further development. The results of formal validation and public feedback were primarily positive. Development needs were also identified and considered. An online Handbook is available.
CONCLUSIONS: The HTA Core Model is a novel approach to HTA. It enables effective international production and sharing of HTA results in a structured format. The face validity of the Model was confirmed during the project, but further testing and refining are needed to ensure optimal usefulness and user-friendliness. Core HTAs are intended to serve as a basis for local HTA reports. Core HTAs do not contain recommendations on technology use.

Entities:  

Mesh:

Year:  2009        PMID: 20030886     DOI: 10.1017/S0266462309990638

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  26 in total

1.  The Importance of Quality Methodological Tools in Telemedicine and COVID-19: The Model for Assessment of Telemedicine (MAST).

Authors:  Gonzalo Segrelles-Calvo; Alicia Gómez-Ramón; Daniel López-Padilla
Journal:  Arch Bronconeumol       Date:  2020-08-11       Impact factor: 4.872

Review 2.  Burden of Disease Study and Priority Setting in Korea: an Ethical Perspective.

Authors:  So Youn Park; Ivo Kwon; In Hwan Oh
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

Review 3.  Ethical issues of obesity surgery--a health technology assessment.

Authors:  Samuli I Saarni; Heidi Anttila; Suoma E Saarni; Pertti Mustajoki; Vesa Koivukangas; Tuija S Ikonen; Antti Malmivaara
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

Review 4.  Transparency in Decision Modelling: What, Why, Who and How?

Authors:  Christopher James Sampson; Renée Arnold; Stirling Bryan; Philip Clarke; Sean Ekins; Anthony Hatswell; Neil Hawkins; Sue Langham; Deborah Marshall; Mohsen Sadatsafavi; Will Sullivan; Edward C F Wilson; Tim Wrightson
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

5.  Participative Facility Planning for Obstetrical and Neonatal Care Processes: Beginning of Life Process

Authors:  Jori Reijula; Sauli Karvonen; Hanna Petäjä; Kari Reijula; Liisa Lehtonen
Journal:  J Healthc Eng       Date:  2016       Impact factor: 2.682

6.  Toward a Method for Exposing and Elucidating Ethical Issues with Human Cognitive Enhancement Technologies.

Authors:  Bjørn Hofmann
Journal:  Sci Eng Ethics       Date:  2016-07-04       Impact factor: 3.525

7.  Valorising and creating access to innovative medicines in the European union.

Authors:  Lieven Annemans; Irina Cleemput; Frank Hulstaert; Steven Simoens
Journal:  Front Pharmacol       Date:  2011-10-11       Impact factor: 5.810

8.  Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.

Authors:  Michèle Tony; Monika Wagner; Hanane Khoury; Donna Rindress; Tina Papastavros; Paul Oh; Mireille M Goetghebeur
Journal:  BMC Health Serv Res       Date:  2011-11-30       Impact factor: 2.655

9.  Health economic modeling to assess short-term costs of maternal overweight, gestational diabetes, and related macrosomia - a pilot evaluation.

Authors:  Irene Lenoir-Wijnkoop; Eline M van der Beek; Johan Garssen; Mark J C Nuijten; Ricardo D Uauy
Journal:  Front Pharmacol       Date:  2015-05-20       Impact factor: 5.810

Review 10.  HOSPITAL MANAGERS' NEED FOR INFORMATION ON HEALTH TECHNOLOGY INVESTMENTS.

Authors:  Anne Mette Ølholm; Kristian Kidholm; Mette Birk-Olsen; Janne Buck Christensen
Journal:  Int J Technol Assess Health Care       Date:  2016-02-15       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.